False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.
about
Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management.A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literaturePheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentSuccinate dehydrogenase gene mutations in cardiac paragangliomasDiagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma.Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasCurrent and future trends in the anatomical and functional imaging of head and neck paragangliomas.Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.Abdominal paragangliomas: a quantitative prognostic score as predictive factor of the feasibility of the laparoscopic approach.Diagnosing endocrine hypertension: a practical approach.Histopathological analysis of spontaneous large necrosis of adrenal pheochromocytoma manifested as acute attacks of alternating hypertension and hypotension: a case report.A Case of a "Voiding" Hypertension.Safety and accuracy of 68Ga-DOTATOC PET/CT in children and young adults with solid tumors.FDG-PET and CT findings of activated brown adipose tissue in a patient with paraganglioma
P2860
Q30412504-E9E77303-E3C0-400B-8C61-A472A91D5CD5Q34029349-F7B8EEFC-D8B7-4345-AD1E-A4DFC2E63BECQ34410500-D3F4F8EF-1683-42AA-96B2-1D8A30F16A39Q35668495-F3D4F409-C89A-4423-AEF9-60956F32205DQ35724965-91C3406E-4400-40B7-AFB4-C302FA598D13Q36021577-C2400227-9343-4641-98FB-1DD425503746Q36467722-EEBCB631-04DB-4C43-BAE7-8C0110967FFBQ36625228-8AF0B897-AAA8-4BBB-8E58-4A44ED10C412Q36724520-511833FC-8E9D-4F8F-BE30-9AAC9763497EQ36804496-B51553C8-E003-4731-9A63-5FE89ECF072FQ37220182-69F4972D-7BBB-4EC0-8E9C-DEAA2CBD75CAQ38580277-D78F50DC-5B85-4128-A540-4163F7FD77BCQ38857083-4C42BB08-9BF8-4B4E-9D6C-6F8CB9E3527BQ38892571-81DEBC63-474A-4106-AC57-DE1358B3D2B7Q39068651-D08B2CF1-413F-4FB6-B8E8-6CA47A440EE4Q39191471-078A5835-48CE-44A6-9ACE-4B5C40AECBFBQ39325833-03ED5044-B92C-4DD2-BDAC-BDAE1891CA6AQ39337899-0F859C86-2B93-4920-9B74-9DD45D1D9682Q41433049-F07AE21C-6E4A-4AD6-99E8-64DB1FFC86D1Q47134854-2C51180E-4ECC-4D35-B145-39D5431CF9F8Q47155891-1212ECF3-3FCB-427A-926A-2714EC746143Q58721362-0A46D0D8-5751-491C-B11D-44ACB04F221A
P2860
False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@ast
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@en
type
label
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@ast
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@en
prefLabel
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@ast
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@en
P2093
P2860
P356
P1476
False-negative ¹²³I-MIBG SPECT ...... to develop metastatic disease.
@en
P2093
Alexander Ling
Clara C Chen
James Reynolds
Jay S Fonte
Jeremyjones F Robles
Karen T Adams
Leilani B Mercado-Asis
Millie Whatley
Victoria Martucci
P2860
P356
10.1530/ERC-11-0243
P50
P577
2012-02-13T00:00:00Z